Reporting Manager
Point72 Asset Management, L.P.
Symbol
RLAY
Shares outstanding
172,380,821 shares
Disclosed Ownership
13,445,704 shares
Ownership
7.8%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:56:15 UTC
Date of event
30 Jun 2025
Previous filing
20 Mar 2025

Sponsored

Quoteable Key Fact

"Point72 Asset Management, L.P. disclosed 7.8% ownership in Relay Therapeutics, Inc. Common Stock, par value $0.001 per share (RLAY) on 30 Jun 2025."

Quick Takeaways

  • Point72 Asset Management, L.P. filed SCHEDULE 13G/A for Relay Therapeutics, Inc. Common Stock, par value $0.001 per share (RLAY).
  • Disclosed ownership: 7.8%.
  • Date of event: 30 Jun 2025.

What Changed

  • Previous schedule filing date: 20 Mar 2025.
  • Current filing was accepted on 14 Aug 2025, 16:56.

Why This Matters

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Official SEC Source

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting Managers (3)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Point72 Asset Management, L.P. 7.8% 13,445,704 0 13,445,704 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Point72 Capital Advisors, Inc. 7.8% 13,445,704 0 13,445,704 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person
Steven A. Cohen 7.8% 13,445,704 0 13,445,704 /s/ Jason M. Colombo Jason M. Colombo, Authorized Person